BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22445595)

  • 21. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China.
    Society of Cardiology, Chinese Medical Association
    Chin Med J (Engl); 2004 Dec; 117(12):1763-7. PubMed ID: 15603701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.
    Ozierański K; Kapłon-Cieślicka A; Peller M; Tymińska A; Balsam P; Galas M; Marchel M; Crespo-Leiro M; Maggioni AP; Drożdż J; Opolski G
    Kardiol Pol; 2016; 74(3):251-61. PubMed ID: 26365943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of atrial fibrillation ablation during mitral surgery in patients with poor electro-anatomical substrate.
    Onorati F; Rubino AS; Mariscalco G; Serraino F; Sala A; Renzulli A
    J Heart Valve Dis; 2009 Nov; 18(6):607-16. PubMed ID: 20099709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY; Breithardt G; Camm J; Crijns H; Dorian P; Kowey PR; Merioua I; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    Am J Cardiol; 2010 Mar; 105(5):687-93. PubMed ID: 20185018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study).
    Roux JF; Zado E; Callans DJ; Garcia F; Lin D; Marchlinski FE; Bala R; Dixit S; Riley M; Russo AM; Hutchinson MD; Cooper J; Verdino R; Patel V; Joy PS; Gerstenfeld EP
    Circulation; 2009 Sep; 120(12):1036-40. PubMed ID: 19738139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study.
    Al-Jazairi MIH; Nguyen BO; De With RR; Smit MD; Weijs B; Hobbelt AH; Alings M; Tijssen JGP; Geelhoed B; Hillege HL; Tieleman RG; Van Veldhuisen DJ; Crijns HJGM; Van Gelder IC; Blaauw Y; Rienstra M;
    Europace; 2021 Sep; 23(9):1359-1368. PubMed ID: 33899093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
    Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.
    Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Groenveld HF; Van den Berg MP; Van Gelder IC;
    Eur J Heart Fail; 2013 Nov; 15(11):1311-8. PubMed ID: 23759284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved.
    Parkash R; Maisel WH; Toca FM; Stevenson WG
    Am Heart J; 2005 Oct; 150(4):701-6. PubMed ID: 16209969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
    de Denus S; Sanoski CA; Carlsson J; Opolski G; Spinler SA
    Arch Intern Med; 2005 Feb; 165(3):258-62. PubMed ID: 15710787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
    Nilsson KR; Al-Khatib SM; Zhou Y; Pieper K; White HD; Maggioni AP; Kober L; Granger CB; Lewis EF; McMurray JJ; Califf RM; Velazquez EJ
    Heart; 2010 Jun; 96(11):838-42. PubMed ID: 20406769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is heart rate important for patients with heart failure in atrial fibrillation?
    Cullington D; Goode KM; Zhang J; Cleland JG; Clark AL
    JACC Heart Fail; 2014 Jun; 2(3):213-20. PubMed ID: 24952686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation in congestive heart failure.
    Seiler J; Stevenson WG
    Cardiol Rev; 2010; 18(1):38-50. PubMed ID: 20010337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation.
    Bui AL; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Yancy CW; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Apr; 165(4):567-574.e6. PubMed ID: 23537974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.